Gene · 1535
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor Microbial Communities and Thyroid Cancer Development-The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions. | Antioxidants (Basel) | 2023 | 37891977 | PubTator, text mining | PubMed |
| NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation. | Antioxidants (Basel) | 2023 | 37891912 | PubTator, text mining | PubMed |
| Genetic Modulation of HPV Infection and Cervical Lesions: Role of Oxidative Stress-Related Genes. | Antioxidants (Basel) | 2023 | 37891885 | PubTator, text mining | PubMed |
| Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity. | Open Biol | 2023 | 37875162 | PubTator, text mining | PubMed |
| Eotaxin-1/CCL11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. | Front Immunol | 2023 | 37860000 | PubTator, text mining | PubMed |
| Targeting NOX2 with Bivalent Small-Molecule p47phox-p22phox Inhibitors. | J Med Chem | 2023 | 37857466 | PubTator, text mining | PubMed |
| (Poly)phenols and the regulation of NADPH oxidases. | Redox Biol | 2023 | 37857000 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis identified pyroptosis-related signature for diagnosis and prognosis in osteoarthritis. | Sci Rep | 2023 | 37853066 | PubTator, text mining | PubMed |
| Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review. | Front Pharmacol | 2023 | 37841935 | PubTator, text mining | PubMed |
| Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection. | Redox Biol | 2023 | 37839355 | PubTator, text mining | PubMed |
| VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity. | Redox Biol | 2023 | 37820403 | PubTator, text mining | PubMed |
| Identifying pathogenic variants related to systemic lupus erythematosus by integrating genomic databases and a bioinformatic approach. | Genomics Inform | 2023 | 37813633 | PubTator, text mining | PubMed |
| Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management. | Cureus | 2023 | 37809154 | PubTator, text mining | PubMed |
| The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies. | J Transl Med | 2023 | 37789439 | PubTator, text mining | PubMed |
| The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection. | Front Immunol | 2023 | 37781389 | PubTator, text mining | PubMed |
Cytomegalovirus and Epstein-Barr Virus Co-infection in a Patient With Chronic Granulomatous Disease Co-existing With Familial Mediterranean Fever and Early-Onset Inflammatory Bowel Disease: A Case Report. | Cureus | 2023 | 37779769 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment. | Microorganisms | 2023 | 37764077 | PubTator, text mining | PubMed |
| Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. | J Clin Med | 2023 | 37763024 | PubTator, text mining | PubMed |
| Ataxia Telangiectasia Arising as Immunodeficiency: The Intriguing Differential Diagnosis. | J Clin Med | 2023 | 37762981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1535/papers?page=9